A HNRNPA0 mutation can affect the expression pattern of phosphatidylinositol-3 kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway, and increase the risk of cancer (Wei et al., 2015). This evidence concerns the gene HNRNPA0 and cancer.